Bethlehem, PA, United States of America

Suhas Gumaste

This inventor holds 3 USPTO granted patents. Top assignee: Genus Lifesciences Inc.. Active years: 2021-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suhas Gumaste. Retrieved from https://idiyas.com/inventor/suhas-gumaste

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Suhas Gumaste: Innovator in Oral Liquid Compositions

Introduction

Suhas Gumaste is a notable inventor based in Bethlehem, PA (US), recognized for his contributions to the field of pharmaceutical formulations. With a total of three patents to his name, he has made significant strides in developing stable oral liquid compositions.

Latest Patents

His latest patents focus on oral liquid compositions that include chlorpromazine. These patents detail stable oral liquid formulations containing chlorpromazine or its pharmaceutically acceptable salts or solvates, along with methods for administering these compositions. This innovation aims to enhance the delivery and efficacy of chlorpromazine in therapeutic applications.

Career Highlights

Suhas Gumaste is currently associated with Genus Lifesciences Inc., where he continues to work on advancing pharmaceutical technologies. His expertise in formulation science has positioned him as a valuable asset in the industry.

Collaborations

One of his notable collaborators is Vaishnavi Parikh, with whom he has worked closely on various projects related to his patents.

Conclusion

Suhas Gumaste's work in developing oral liquid compositions represents a significant advancement in pharmaceutical formulations, showcasing his dedication to improving patient care through innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…